Systematic analysis of the TGF-β/Smad signalling pathway in the rhabdomyosarcoma cell line RD
- 16 September 2003
- journal article
- Published by Wiley in International Journal of Experimental Pathology
- Vol. 84 (3), 153-163
- https://doi.org/10.1046/j.1365-2613.2003.00347.x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- TGFβ Signaling in Growth Control, Cancer, and Heritable DisordersCell, 2000
- Transcriptional Activators of TGF-β Responses: SmadsCell, 1998
- Mads and Smads in TGFβ signallingCurrent Opinion in Cell Biology, 1998
- TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4The EMBO Journal, 1997
- Soft tissue tumours in childhoodHistopathology, 1993
- Deficiency in Rhabdomyosarcomas of a Factor Required for MyoD Activity and MyogenesisScience, 1993
- Physiological Actions and Clinical Applications of Transforming Growth Factor-β (TGF-β)Growth Factors, 1993
- The myoD Gene Family: Nodal Point During Specification of the Muscle Cell LineageScience, 1991
- The Transforming Growth Factor-beta FamilyAnnual Review of Cell Biology, 1990
- Extension of the Life-Span of Human Endothelial Cells by an Interleukin-1αAntisense OligomerScience, 1990